354 related articles for article (PubMed ID: 19491279)
1. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.
Qian F; Villella J; Wallace PK; Mhawech-Fauceglia P; Tario JD; Andrews C; Matsuzaki J; Valmori D; Ayyoub M; Frederick PJ; Beck A; Liao J; Cheney R; Moysich K; Lele S; Shrikant P; Old LJ; Odunsi K
Cancer Res; 2009 Jul; 69(13):5498-504. PubMed ID: 19491279
[TBL] [Abstract][Full Text] [Related]
2. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
Löb S; Königsrainer A; Zieker D; Brücher BL; Rammensee HG; Opelz G; Terness P
Cancer Immunol Immunother; 2009 Jan; 58(1):153-7. PubMed ID: 18418598
[TBL] [Abstract][Full Text] [Related]
3. Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.
Lob S; Konigsrainer A; Schafer R; Rammensee HG; Opelz G; Terness P
Blood; 2008 Feb; 111(4):2152-4. PubMed ID: 18045970
[TBL] [Abstract][Full Text] [Related]
4. Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation.
Qian F; Liao J; Villella J; Edwards R; Kalinski P; Lele S; Shrikant P; Odunsi K
Cancer Immunol Immunother; 2012 Nov; 61(11):2013-20. PubMed ID: 22527253
[TBL] [Abstract][Full Text] [Related]
5. Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques.
Boasso A; Vaccari M; Fuchs D; Hardy AW; Tsai WP; Tryniszewska E; Shearer GM; Franchini G
J Immunol; 2009 Apr; 182(7):4313-20. PubMed ID: 19299731
[TBL] [Abstract][Full Text] [Related]
6. Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice.
Nakamura N; Hara T; Shimizu M; Mabuchi R; Nagano J; Ohno T; Kochi T; Kubota M; Shirakami Y; Goto N; Ito H; Saito K; Tanaka T; Moriwaki H; Tsurumi H
Int J Hematol; 2015 Sep; 102(3):327-34. PubMed ID: 26243621
[TBL] [Abstract][Full Text] [Related]
7. Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma.
Inaba T; Ino K; Kajiyama H; Yamamoto E; Shibata K; Nawa A; Nagasaka T; Akimoto H; Takikawa O; Kikkawa F
Gynecol Oncol; 2009 Nov; 115(2):185-92. PubMed ID: 19665763
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of indoleamine 2,3-dioxygenase by stereoisomers of 1-methyl tryptophan in an experimental graft-versus-tumor model.
Lim JY; Lee SE; Park G; Choi EY; Min CK
Exp Hematol; 2014 Oct; 42(10):862-6.e3. PubMed ID: 24971697
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.
Hou DY; Muller AJ; Sharma MD; DuHadaway J; Banerjee T; Johnson M; Mellor AL; Prendergast GC; Munn DH
Cancer Res; 2007 Jan; 67(2):792-801. PubMed ID: 17234791
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection.
Fox JM; Sage LK; Huang L; Barber J; Klonowski KD; Mellor AL; Tompkins SM; Tripp RA
J Gen Virol; 2013 Jul; 94(Pt 7):1451-1461. PubMed ID: 23580425
[TBL] [Abstract][Full Text] [Related]
11. Influence of tryptophan contained in 1-Methyl-Tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase.
Schmidt SK; Siepmann S; Kuhlmann K; Meyer HE; Metzger S; Pudelko S; Leineweber M; Däubener W
PLoS One; 2012; 7(9):e44797. PubMed ID: 23028625
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.
Terness P; Bauer TM; Röse L; Dufter C; Watzlik A; Simon H; Opelz G
J Exp Med; 2002 Aug; 196(4):447-57. PubMed ID: 12186837
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of IDO1, D-1-methyl-tryptophan (D-1MT), effectively increased EpCAM/CD3-bispecific BiTE antibody MT110 efficacy against IDO1
Hong R; Zhou Y; Tian X; Wang L; Wu X
Int Immunopharmacol; 2018 Jan; 54():118-124. PubMed ID: 29128855
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan.
Zhang X; Yang Y; Zhang L; Lu Y; Zhang Q; Fan D; Zhang Y; Zhang Y; Ye Z; Xiong D
J Hematol Oncol; 2017 Feb; 10(1):56. PubMed ID: 28228105
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.
Eleftheriadis T; Pissas G; Antoniadi G; Spanoulis A; Liakopoulos V; Stefanidis I
Int Immunol; 2014 Dec; 26(12):673-84. PubMed ID: 25064493
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.
Hwu P; Du MX; Lapointe R; Do M; Taylor MW; Young HA
J Immunol; 2000 Apr; 164(7):3596-9. PubMed ID: 10725715
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.
Hwang SL; Chung NP; Chan JK; Lin CL
Cell Res; 2005 Mar; 15(3):167-75. PubMed ID: 15780178
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy. Laboratory investigation.
Miyazaki T; Moritake K; Yamada K; Hara N; Osago H; Shibata T; Akiyama Y; Tsuchiya M
J Neurosurg; 2009 Aug; 111(2):230-7. PubMed ID: 19199463
[TBL] [Abstract][Full Text] [Related]
19. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.
Boasso A; Herbeuval JP; Hardy AW; Anderson SA; Dolan MJ; Fuchs D; Shearer GM
Blood; 2007 Apr; 109(8):3351-9. PubMed ID: 17158233
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice.
Ufermann CM; Domröse A; Babel T; Tersteegen A; Cengiz SC; Eller SK; Spekker-Bosker K; Sorg UR; Förster I; Däubener W
Front Cell Infect Microbiol; 2019; 9():184. PubMed ID: 31231617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
